Britain’s Avacta Group has halted sales of its COVID-19 lateral flow test in order to replace the antibody in the device and ensure its effectiveness.
Global Roundup: BICO Group Snaps up Biosero and its Software Solutions - read this article along with other careers information, tips and advice on BioSpace